Open Access
Combination of RNA Interference and Virus Receptor Trap Exerts Additive Antiviral Activity in Coxsackievirus B3-induced Myocarditis in Mice
The Journal Of Infectious DiseasesPeer ReviewedElisabeth Stein +102014Journals
Coxsackievirus B3 (CVB3) is a major heart pathogen against which no therapy exists to date. The potential of a combination treatment consisting of a proteinaceous virus receptor trap and an RNA interference-based component to prevent CVB3-induced myocarditis was investigated.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support